Esri Enters into Memorandum of Understanding with UN-Habitat
Patient recruitment starts for the international PRO-SID study evaluating Panzyga® for primary prophylaxis in patients with chronic lymphocytic leukaemia and secondary immunodeficiency
BOEHRINGER INGELHEIM AND MIRATI THERAPEUTICS ANNOUNCE CLINICAL COLLABORATION TO STUDY BI 1701963, A SOS1::PAN-KRAS INHIBITOR IN COMBINATION WITH MRTX849, A KRAS G12C SELECTIVE INHIBITOR
Corporate Social Responsibility Related News Releases and Story Ideas for Reporters, Bloggers and Media Outlets
Bdiapers India Launches India's First Hybrid Cloth Diapers with Disposable Inserts
CENTRESTAGE Virtual Runway Shows Begin Today